Evidence map›Paper›PMID 24942584›Full record

ArticleJournal of virology2014

The West Nile virus-like flavivirus Koutango is highly virulent in mice due to delayed viral clearance and the induction of a poor neutralizing antibody response.

Natalie A Prow, Yin X Setoh, Rebecca M Biron, David P Sester, Kwang Sik Kim, Jody Hobson-Peters, Roy A Hall, Helle Bielefeldt-Ohmann

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
8.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 43 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Natalie A ProwAustralian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, Queensland, Australia School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia n.prow@uq.edu.au.
Yin X SetohAustralian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, Queensland, Australia School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.
Rebecca M BironAustralian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, Queensland, Australia School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.
David P SesterAustralian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, Queensland, Australia School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.
Kwang Sik KimDepartment of Pediatrics, Division of Pediatric Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jody Hobson-PetersAustralian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, Queensland, Australia School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.
Roy A HallAustralian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, Queensland, Australia School of Chemistry and Molecular Biosciences, The University of Queensland, St. Lucia, Queensland, Australia.
Helle Bielefeldt-OhmannAustralian Infectious Diseases Research Centre, The University of Queensland, St. Lucia, Queensland, Australia School of Veterinary Science, The University of Queensland, Gatton, Queensland, Australia.
University of Queensland · AUJohns Hopkins University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

unlabelledThe mosquito-borne West Nile virus (WNV) is responsible for outbreaks of viral encephalitis in humans, horses, and birds, with particularly virulent strains causing recent outbreaks of disease in eastern Europe, the Middle East, North America, and Australia. Previous studies have phylogenetically separated WNV strains into two main genetic lineages (I and II) containing virulent strains associated with neurological disease. Several WNV-like strains clustering outside these lineages have been identified and form an additional five proposed lineages. However, little is known about whether these strains have the potential to induce disease. In a comparative analysis with the highly virulent lineage I American strain (WNVNY99), the low-pathogenicity lineage II strain (B956), a benign Australian strain, Kunjin (WNVKUN), the African WNV-like Koutango virus (WNVKOU), and a WNV-like isolate from Sarawak, Malaysia (WNVSarawak), were assessed for neuroinvasive properties in a murine model and for their replication kinetics in vitro. While WNVNY99 replicated to the highest levels in vitro, in vivo mouse challenge revealed that WNVKOU was more virulent, with a shorter time to onset of neurological disease and higher morbidity. Histological analysis of WNVKOU- and WNVNY99-infected brain and spinal cords demonstrated more prominent meningoencephalitis and the presence of viral antigen in WNVKOU-infected mice. Enhanced virulence of WNVKOU also was associated with poor viral clearance in the periphery (sera and spleen), a skewed innate immune response, and poor neutralizing antibody development. These data demonstrate, for the first time, potent neuroinvasive and neurovirulent properties of a WNV-like virus outside lineages I and II. IMPORTANCE: In this study, we characterized the in vitro and in vivo properties of previously uncharacterized West Nile virus strains and West Nile-like viruses. We identified a West Nile-like virus, Koutango virus (WNVKOU), that was more virulent than a known virulent lineage I virus, WNVNY99. The enhanced virulence of WNVKOU was associated with poor viral clearance and the induction of a poor neutralizing antibody response. These findings provide new insights into the pathogenesis of West Nile virus.

Indexed as

AnimalsAntibodies, NeutralizingAntibodies, ViralBrainDisease Models, AnimalEncephalitis, ArbovirusEncephalitis Viruses, JapaneseFlavivirus InfectionsMiceSpinal CordSurvival AnalysisVirulenceVirus ReplicationAntibodies, NeutralizingAntibodies, Viral

Identifiers

PMID24942584
PMCPMC4136322
OpenAlexW2131084229

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.